Rama Al Hamed

Rama Al Hamed: Allogeneic SCT in de novo core-binding factor AML in first complete remission

Rama Al Hamed, Hematology/Oncology Fellow at Herbert Irving Comprehensive Cancer Centre, shared on X:

“Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT.

Worse outcomes with consolidation with alloSCT in CR1 compared to ASCT.”

Source: Rama Al Hamed/X

Rama Al Hamed

Authors: Rama Al Hamed, Myriam Labopin, Depei Wu, Tobias Gedde-Dahl, Mahmoud Aljurf, Edouard Forcade, Urpu Salmenniemi, Jakob Passweg, Johan Maertens, Thomas Pabst, Jurjen Versluis, Maija Itäla-Remes, Xiao-Jun Huang, Gwendolyn Van Gorkom, Thomas Schroeder, Jaime Sanz, Didier Blaise, Péter Reményi, Urs Schanz, Jordi Esteve, Norbert-Claude Gorin, Fabio Ciceri, Mohamad Mohty

Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT

Acute Myeloid Leukemia alloSCT AML cancer Depei Wu Didier Blaise EBMT Edouard Forcade Fabio Ciceri Gwendolyn Van Gorkom Herbert Irving Comprehensive Cancer Centre Jaime Sanz Jakob Passweg Johan Maertens Jordi Esteve Jurjen Versluis Mahmoud Aljurf Maija Itäla-Remes Mohamad Mohty Myriam Labopin Norbert-Claude Gorin OncoDaily Oncology Péter Reményi Rama Al Hamed Thomas Pabst Thomas Schroeder Tobias Gedde-Dahl Urpu Salmenniemi Urs Schanz Xiao-Jun Huang